San Jose, CA (PRWEB) January 20, 2014
Follow us on LinkedIn – Genes can be defined as the basic molecular units of heredity in a living organism, holding information on creating and maintaining the cells of an organism and passing genetic traits to its offspring. Radio controlled genes refers to remotely activating genes inside the human body through the use of electromagnetic waves to guide the movement of nanoparticles injected inside the body. As the next frontier of medical science, radio controlled genes is attracting immense R&D interest and investment, given its potential to offer non-invasive and non-pharmacological treatment possibilities. Using radio waves to control gene expression has the advantage of being safe as radio waves, unlike electrical waves, do not damage tissues. Advancements in nanobiotechnology and development of antibody coated metal nanoparticles as carriers to absorb radio frequency energy are expected to help drive growth in the market. Currently, being researched is the possibility of using radiowaves to induce insulin-gene expression and activate insulin production in the body to treat diabetes.
The trend report titled “Radio-Controlled Genes” announced by Global Industry Analysts Inc., is a focused research paper which provides cursory insights into the technology, its applications, and future prospects.
For more details about this trend report, please visit http://www.strategyr.com/TrendReport.asp?code=141011.
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/